the basis for multiple action
variants and alternative paths to achieving goals. Schematization, in turn
Ivanova, E.,
Gilyazova, I.,
Pavlov, V.,
Izmailov, A.,
Gimalova, G.,
Karunas, A.,
Prokopenko, I.,
Khusnutdinova, E. (2022) variants, located in microRNA biogenesis genes, in 464 individuals with clinically diagnosed ccRCC and 1042
Timasheva, Y.,
Balkhiyarova, Z.,
Avzaletdinova, D.,
Rassoleeva, I.,
Morugova, T.V.,
Korytina, G.,
Prokopenko, I.,
Kochetova, O. (2023) We tested associations between 13 established genetic
variants and type 2 diabetes (T2D) in 1371
Kazantseva, A.V.,
Davydova, Y.D.,
Enikeeva, R.F.,
Valinurov, R.G.,
Gareeva, A.E.,
Khusnutdinova, N.N.,
Khusnutdinova, E.K. (2021) (rs2228485, rs53576) and AVPR1B (rs33911258) gene
variants was conducted via PCR with fluorescent
Kazantseva, A.,
Enikeeva, R.,
Takhirova, Z.,
Davydova, Y.,
Mustafin, R.,
Malykh, S.,
Karunas, A.,
Kanapin, A.,
Khusnutdinova, E. (2023) and SLC6A20 gene
variants (OR = 2.36, 95% CI 1.31–4.24) and OR = 1.94, 95% CI 1.08–3.49, respectively